Testing for efficacy in adaptive clinical trials with enrichment

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Pharmaceutical Development

Background:

• Adaptive clinical trial designs offer potential cost and time savings in drug development.
• Heterogeneous patient populations pose challenges for assessing treatment effectiveness.
• Enrichment designs adaptively identify patient subpopulations for focused treatment effect assessment.

Purpose of the Study:

• To develop and evaluate methods for adaptive enrichment designs in two-arm randomized clinical trials.
• To present a hypothesis testing procedure and confidence limit for treatment effects in selected subgroups.
• To compare the performance of new methods against existing approaches via simulation.

Main Methods:

• Utilized accumulating data from clinical trials to adaptively select patient subpopulations.
• Developed a hypothesis testing procedure for treatment effects in identified subgroups.
• Constructed a lower confidence limit for treatment effects in selected subgroups.
• Employed simulation studies to compare proposed methods with existing ones.

Main Results:

• The proposed hypothesis testing procedure and lower confidence limit provide tools for assessing treatment effects in enriched subpopulations.
• Simulation results demonstrate the performance of the new methods in adaptive enrichment designs.
• The study offers a comparative analysis of novel adaptive strategies against traditional approaches.

Conclusions:

• Adaptive enrichment designs are valuable for efficiently assessing treatment effects in heterogeneous populations.
• The presented methods offer statistically sound approaches for subgroup analysis in adaptive trials.
• This research contributes to optimizing clinical trial efficiency and effectiveness through adaptive strategies.